The identification of lymphocyte subsets with non-overlapping effector functions has been pivotal to the development of targeted therapies in immune-mediated inflammatory diseases (IMIDs) 1,2 . However, it remains unclear whether fibroblast subclasses with non-overlapping functions also exist and are responsible for the wide variety of tissue-driven processes observed in IMIDs, such as inflammation and damage 3-5 . Here we identify and describe the biology of distinct subsets of fibroblasts responsible for mediating either inflammation or tissue damage in arthritis. We show that deletion of fibroblast activation protein-α (FAPα) + fibroblasts suppressed both inflammation and bone erosions in mouse models of resolving and persistent arthritis. Single-cell transcriptional analysis identified two distinct fibroblast subsets within the FAPα 
. However, it remains unclear whether fibroblast subclasses with non-overlapping functions also exist and are responsible for the wide variety of tissue-driven processes observed in IMIDs, such as inflammation and damage 3-5 . Here we identify and describe the biology of distinct subsets of fibroblasts responsible for mediating either inflammation or tissue damage in arthritis. We show that deletion of fibroblast activation protein-α (FAPα) + fibroblasts suppressed both inflammation and bone erosions in mouse models of resolving and persistent arthritis. Single-cell transcriptional analysis identified two distinct fibroblast subsets within the FAPα 
THY1
− fibroblasts selectively mediate bone and cartilage damage with little effect on inflammation, whereas transfer of FAPα + THY1 + fibroblasts resulted in a more severe and persistent inflammatory arthritis, with minimal effect on bone and cartilage. Our findings describing anatomically discrete, functionally distinct fibroblast subsets with non-overlapping functions have important implications for cell-based therapies aimed at modulating inflammation and tissue damage.
Non-haematopoietic, tissue-resident fibroblasts contribute to the pathogenesis of many diseases and are known to develop epigenetically imprinted, site-and disease-specific phenotypes [6] [7] [8] . Rheumatoid arthritis (RA) is a prototypic IMID 6 in which synovial fibroblasts contribute to both joint damage 7, 8 and inflammation 9 . We found that expression of FAPα, a cell-membrane dipeptidyl peptidase 10 , was significantly higher in both synovial tissue and cultured synovial fibroblasts isolated from patients who fulfilled classification criteria for RA compared to patients in whom joint inflammation resolved (Fig. 1a-c) , suggesting that FAPα expression may associate with a pathogenic fibroblast phenotype.
To map the expression of FAPα-expressing cells in the RA synovium, we used mass cytometry (CyTOF), together with a combination of podoplanin (PDPN) and thymus cell antigen 1 (THY1, also known as CD90) to discriminate sub-lining layer (SL, THY1 + ) from lining layer (LL, THY1 − ) fibroblasts, as in previous studies 4, 5, 11 . FAPα colocalized with PDPN in both the LL and SL cells (Fig. 1d) . A small subset of pericytes (defined as CD45 −
PDPN
− and THY1 + ) also expressed FAPα. These findings were confirmed by confocal analysis in RA synovial tissue (Fig. 1e) .
To determine the role of FAPα + synovial fibroblasts in arthritis, we used serum transfer induced arthritis (STIA) 12 in a transgenic FAPα luciferase-DTR reporter mouse 13 . FAPα expression (bioluminescence) increased during the course of arthritis (Fig. 1f, g ) and correlated with the severity of ankle joint swelling (Fig. 1h ). Synovial expression of FAPα was either low or undetectable under resting conditions (Extended Data Fig. 1a ) but increased in synovial membrane and focal areas of pannus tissue invading cartilage and bone during inflammation (Fig. 1i, j, Extended Data Fig. 1a) . FAPα expression was restricted to mesenchymal cells (CD45 − ) (Extended Data Fig. 1b-f ) and the number of FAPα + fibroblasts increased during inflammation and returned to baseline levels with resolution of inflammation (Fig. 1k, Extended Data Fig. 1c, d) , confirming that FAPα is a biomarker of tissue inflammation Extended Data Fig. 1a, c, d) .
In the mouse synovium, THY1 expression also distinguished SL from LL fibroblasts, whereas FAPα was expressed in both cellular compartments (Extended Data Fig. 1e-g ). Induction of Pdpn, Fap and Thy1 mRNA was significantly higher in the inflamed synovial membrane (Fig. 1l) , and expression positively correlated with joint swelling (Fig. 1m) . A significant increase in the proliferation of both THY1 
THY1
− cells (Extended Data Fig. 1j ). Collectively, these data suggest that the expansion of a potentially pathogenic population of synovial fibroblasts is marked by expression of PDPN, FAPα and THY1.
To determine the functional role of FAPα + fibroblasts in vivo, we selectively depleted FAPα + cells during arthritis (Extended Data Fig. 1k-m) . Deletion of these cells led to a significant reduction in the cellularity of the synovial membrane (Extended Data Fig. 1n-p) , attenuated synovial inflammation and accelerated resolution in both the resolving (Fig. 2a ) and persistent models of STIA (Fig. 2b) , with the same effect observed regardless of the stage of arthritis at the time of deletion (Extended Data Fig. 2a, b) . However, deletion before induction of arthritis had no effect on joint thickness (Extended Data Fig. 2c ), an observation consistent with the low numbers of FAPα + cells in the synovial membrane under resting conditions (Extended Data Fig. 1a, c) .
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Deletion of FAPα
+ cells reduced structural joint damage (cartilage and bone damage), inflammatory bone remodelling, pannus formation (Fig. 2c, , osteoclast numbers (Fig. 2d, Extended Data Fig. 2g, h ) and expression of osteoclast and osteoblast bone markers in whole joint tissue (Extended Data Fig. 2i ).
FAPα + cell deletion led to reduced leukocyte infiltration ( Fig. 2e ), negatively correlated with the severity of joint inflammation (Fig. 2f) and was associated with a reduction in the number of both LL and SL fibroblasts, with no significant change in pericyte numbers (Fig. 2g) . Circulating blood monocyte number and phenotype were unchanged (Extended Data Fig. 3a) , excluding any potential indirect effects of myelosuppression. Accompanying these changes was a marked reduction in the number of synovial leukocytes, specifically neutrophils, macrophages, CD11b
+ dendritic cells and monocytes, but not eosinophils (Extended Data Fig. 3b for gating strategy, Fig. 2h for resolving STIA model data and Extended Data Fig. 3c for persistent model), and a reduction in the percentage of major histocompatibility complex (MHC) class II-expressing macrophages (persistent model: Extended Data Fig. 3c ; resolving model: Extended Data Fig. 3e ). There were very few remaining macrophages in the synovial membrane following deletion of FAPα + cells (Extended Data Fig. 3d ) and those remaining had a more anti-inflammatory phenotype (Extended Data Fig. 3f ). These cellular changes in the synovium were accompanied by a marked reduction in pro-inflammatory chemokines, cytokines, RANKL and matrix metalloproteases (MMPs) (Fig. 2i) , demonstrating that synovial FAPα + cells are a major source of these proteins.
To exclude an indirect effect of systemic deletion of FAPα + cells, we delivered diphtheria toxin locally to the joint. This resulted in cell deletion in the synovial membrane but not in draining or distant lymph nodes (Extended Data Fig. 3g ) and did not result in systemic cachexia (Extended Data Fig. 3h ), as reported previously after systemic FAPα + -cell deletion 13 . Local deletion had the same effect on joint inflammation and bone damage with no effect observed in non-injected joints or following administration of diphtheria toxin in non-arthritic mice (Extended Data Fig. 3i-k) .
We next investigated whether both THY1 − FAPα + (LL) and THY1 + FAPα + (SL) fibroblast populations contribute equally to inflammation and bone damage. We first performed single-cell RNA sequencing of CD45 − non-haematopoietic cells from inflamed mouse synovium. After assigning identities to all cell clusters (Fig. 3a, 5, Supplementary Table 1) , targeted reanalysis of the fibroblast populations on the basis of expression of known fibroblast markers revealed the existence of five distinct subgroups that we designate Extended Data Figs. 6, 7, Supplementary Table  1) . Gene ontology (GO) analysis of significant cluster marker genes suggested a diversification of function between the subsets. F1 fibroblast marker genes were over-represented in categories related to bone, cartilage and extra-cellular matrix formation. F2 cells were strongly characterized by expression of inflammatory genes, including those involved in 'cytokine production' and 'regulation of leukocyte chemotaxis' . Meanwhile, F3 fibroblasts showed an enrichment for genes involved in the 'complement activation' and 'vasculogenesis' biological processes. F4 fibroblasts expressed genes characteristic of an actively cell cycling population. Finally, F5 fibroblasts displayed a phenotype that included a distinctive over-representation of genes associated with 'acid secretion' and 'hydrogen transport' (Fig. 3c, Supplementary Table 2) .
Examination of the top cluster marker genes allowed us to easily differentiate these five subsets at the mRNA expression level (Fig. 3d) . Whereas Pdpn and Fap were expressed by all of the fibroblast subsets, Thy1 was expressed selectively by F1-F4 fibroblasts but not F5 fibroblasts (Fig. 3d, Extended Data Fig. 6 ), suggesting that we could use THY1 as a marker to discriminate the LL F5 subset from the four SL clusters (F1-F4). We also examined the expression of other known fibroblast markers across the subsets as well as the specific expression of selected chemokines (Extended Data Fig. 7a,c) .
We next examined the potential developmental relationship between the different fibroblast subsets using a diffusion map (Fig. 3e) . 
Fig. 1 | FAPα + SFs accumulate in the arthritic joint. a, Representative images of FAPα expression in synovial tissue. b, Quantification of data in a. P ≤ 0.0001. c, Matched Fap transcript expression in synovial fibroblasts expanded in vitro. Con versus RA: P ≤ 0.0001; Res versus RA: P ≤ 0.01 (a-c; n = 8 control, 9 resolving and 11 RA patient samples). Con, control; Res, resolving. Scale bar, 100 μm. d, CyToF viSNE plots of CD45 − cells. e, Confocal microscopy of RA synovium (both d and e representative of n = 8 RA patient samples). Scale bar, 100 μm. f, g, Serial measurements of bioluminescence signal in FAPα-luciferase mice (f) and quantification during STIA (g; n = 8 mice). P values versus day 0; front paw: P = 0.0001 (4 days and 9 days), P = 0.019 (15 days); hind paw: P = 0.036 (4 days), P = 0.0001 (9 days), P = 0.0001 (15 days) . h, Spearman's correlation between bioluminescence and joint thickness (n = 30 mice; P ≤ 0.0001). i, j, Representative image of FAPα (red) expression in hind limb joints of day 9 STIA mice, (i; arrows indicate FAPα expression) and quantification (j; n = 10 mice per group). P =0.0001. Scale bars in i: top left, 100 μm; top right, 50 μm; bottom left, 80 μm; bottom right, 20 μm. k, Fap transcript expression in sort-purified synovial CD45
− CD31 − cells during STIA (n = 8 mice per time point; P values versus day 3; P = 0.0024 (day 5), P = 0.0227 (day 7), P = 0.0001 (day 9), P = 0.0001 (day 12)). l, Fold change in mRNA expression of stromal markers in the synovia of day 9 STIA compared to control mice (n = 8 mice; P = 0.0025). m, Spearman's correlation between combined expression of Pdpn, Thy1 and Fap, and ankle joint thickness (n = 44 mice). n, Change in absolute numbers (LL versus SL: P ≤ 0.0001 for day 3-15, P = 0.0073 for day 18) and percentage of Ki67 + (LL versus SL: P= 0.049 for day 3, P ≤ 0.0001 for day 7-12) and BrdU + (LL versus SL: P = 0.024 at day 5 and P ≤ 0.0001 for day 7-22) cells during STIA (n = 6 mice). Statistics: Kruskal-Wallis with Dunn's post hoc test (b, c); one-way ANOVA with Dunnett's post hoc test, compared to day 0 (g) or day 3 (k); two-tailed Mann-Whitney test (j); two-way ANOVA with Tukey's post hoc test (l, n). Data are mean ± s.d., except in k, l, which are shown as box plots (centre line, median; box limits, upper and lower quartiles; whiskers, maximum and minimum values).
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Application of the pseudotime algorithm Slingshot 14 , identified two single-branch trajectories comprising of F1-F2-F3-F4 and F1-F2-F5. Existence of the F1-F2-F5 trajectory is consistent with the topology of the diffusion map, and analysis of genes that are differentially expressed along this trajectory (Extended Data Fig. 8a ) showed that cells of cluster F2 have overlapping profiles with those of F1 and F5.
To investigate the existence of homologous fibroblast subsets in human arthritis, we selectively reanalysed data from synovial biopsies from people with RA 15 . This analysis identified five distinct subpopulations (Extended Data Fig. 8b-e) . Correlation of orthologous (one-to-one) cluster markers from the human and mouse datasets identified three homologous populations of fibroblasts (Fig. 3f ) that share distinctive gene expression profiles (Fig. 3g) Data Fig. 9b ). The THY1 + cell population showed expression of many chemokines and cytokines and expressed F1-F4 subset-specific genes (Extended Data Fig. 9c, d ). By contrast, THY1
− cell gene expression was consistent with F5 fibroblast-associated genes such as Prg4, Clic5 and Tspan15 as well as genes associated with cartilage and bone erosion. Therefore the greatest determinant of the transcriptional profile of synovial fibroblasts appeared to be their anatomical location in the synovial membrane (as defined by THY1 expression).
As predicted from the single-cell transcriptome analysis, FAPα + THY1 + subsets had an immune-effector profile with higher expression of chemokines as well as cytokines including: Il6, Lif, Il33 and Il34. By contrast, FAPα +
THY1
− subsets had higher expression of Ccl9 and Tnfsf11, both potent inducers of osteoclast activity, as well as Mmp3, Mmp9 and Mmp13, which are MMPs involved in cartilage degradation (Extended Data Fig. 9d ). These findings were validated, when possible, for protein expression (Fig. 4a) . FAPα 
− cells also expressed receptor activator of nuclear factor-kappa B ligand (RANKL) on their surface, secreted higher levels of RANKL, exhibited a significantly increased RANKL:osteoprotegerin (OPG) ratio (Fig. 4b, c) and stimulated osteoclast differentiation and activation in vitro, leading to significantly more resorption of hydroxyapatite matrix in vitro (Fig. 4d) Thickness ( − , n = 9) STIA mice compared to non-arthritic deleted (DTR + , n = 6) and non-deleted (DTR − , n = 6) mice, with area under the curve (AUC) analysis. P ≤ 0.0001. DTx, diphtheria toxin. AU, arbitrary units. b, Effect of sustained FAPα cell deletion on joint inflammation in persistent STIA (DTR + and DTR − , n = 8) mice, and nonarthritic (DTR + and DTR − , n = 4) mice, with AUC analysis. P ≤ 0.0001. c, Representative micro computed tomography (micro-CT) and histological images of day 28 persistent STIA mice. Arrows indicate areas of interest (n = 16 mice per group). Scale bars, 100 μm. d, Quantification of micro-CT data, osteoclast number and histomorphometric analysis of bone erosion, pannus formation and cartilage damage. P ≤ 0.0001. e, Representative histology at day 9 STIA and quantification (n = 14 mice per group; P = 0.0034). Arrow shows leukocyte infiltration. SM, synovial membrane. Scale bars, 100 μm. f, Spearman's correlation between the percentage of FAPα cell deletion achieved at day 9 and change in ankle joint thickness (n = 45 mice). P ≤ 0.0001. g, Quantification of the number of fibroblasts and pericytes (n = 8 mice) and leukocyte subsets (n = 13 mice) in day 9 STIA synovia analysed by flow cytometry. P ≤ 0.0001, except for macrophages: P = 0.0256. h, Expression of selected mRNA transcripts. i, Expression of selected proteins (by luminex analysis following stimulation ex vivo with TNF) in the synovia of DTR − and DTR + day 9 STIA mice following treatment with diphtheria toxin, expressed as fold change in expression compared to non-arthritic mice (n = 8 mice per group for mRNA and n = 6 mice per group for protein analysis). Statistics: one-way ANOVA with Dunnett's multiple comparison test (a, b), two-tailed paired Student's t-test (d, e), two-way ANOVA with Tukey's multiple comparison test (g). Data are mean ± s.d., except AUC analyses (a, b, g), which are shown as box plots (centre line, median; box limits, upper and lower quartiles; whiskers, maximum and minimum values).
Letter reSeArCH during STIA. Injection of PDPN + FAPα + THY1 + cells resulted in more severe and sustained joint swelling ( Fig. 4e ) with higher levels of leukocyte infiltration (Fig. 4f) , but had little effect on bone and cartilage destruction (Fig. 4g, h ). By contrast, injection of PDPN + FAPα + THY1 − cells had no effect on the severity or temporal dynamics of joint inflammation (Fig. 4e, f) , but did result in increased osteoclast activity and increased structural joint damage ( Fig. 4g, h ). Similar effects were observed following the injection of each cell population into an inflamed ankle joint of mice with collagen induced arthritis (CIA) (Extended Data Fig. 10a, b) . In this case, injection of PDPN + FAPα + THY1 + cells also resulted in increased effector CD4 + T cells, reduced FOXP3 + T regulatory cells, and a global increase in neutrophil and macrophage cell infiltration (Extended Data Fig. 10c ).
Following joint injection, cells engrafted into the synovial membrane remained largely at the site of injection and were detectable up to 14 days after injection (Extended Data Fig. 10d ). They maintained their original cell phenotype with regards to THY1 expression (Extended Data Fig. 10e ) but did not preferentially localize to any specific anatomical compartment of the synovial membrane. No significant difference in the level of engraftment or viability between injected cell populations was observed (Extended Data Fig. 10f ). Collectively, these data suggest that in pathological conditions, PDPN
+ cells assume an immune effector role capable of sustaining inflammation through the production of a distinct repertoire of chemokines and cytokines, whereas PDPN
− cells are bone effector cells that mediate joint damage.
In support of this conclusion, and as validation of the relevance of our findings to human disease, we identified an expanded population of PDPN
+ immune effector fibroblasts in the synovia of patients with RA, in whom joints are persistently inflamed, compared to patients with osteoarthritis, which is a disease characterized predominately by cartilage damage rather than inflammation (Fig. 4i ). The expansion of PDPN + THY1 + FAPα + cells positively correlated with markers of systemic and tissue inflammation (Fig. 4j) .
In summary, we have identified and described the pathological significance of fibroblast heterogeneity in RA, an IMID in which inflammation and damage play key pathogenic roles. We describe discrete, anatomically distinct subsets of fibroblasts with non-overlapping effectorcell functions, including joint and cartilage damage (production of MMPs and induction of osteoclastogenesis) and immuno-inflammatory regulation (production of inflammatory cytokines and chemokines). These findings provide the underlying justification for the development of therapies that selectively target deletion or replacement of different mesenchymal subpopulations in a wide range of diseases.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-1263-7. 16 of fibroblasts (n = 1,725 cells) reveals five subsets (F1-F5) in the inflamed STIA joints. c, d, Conserved cluster marker genes were first identified as those with a maximum Benjamini-Hochberg adjusted P < 0.1 in separate tests of cells from each of the n = 3 biological replicates (two-sided Wilcoxon tests, Supplementary Table 1) . c, Over-representation analysis of GO categories suggests different functions for the five STIA fibroblast subsets. Significant enrichments amongst cluster markers (Benjamini-Hochberg adjusted P < 0.05, one-sided Fisher's exact tests, Supplementary + cells isolated from day 9 STIA synovia were stimulated and analysed using luminex. P ≤ 0.0001, except: CXCL12, P = 0.0002; CCL2, P = 0.0001; CCL7, P =0.0028; CCL12, P = 0.0016; IL-6, P = 0.0013; MMP9, P = 0.0019 (n = 6 mice per group). b, c, Secretion of RANKL and OPG (b; n = 6 mice per group; RANKL, P = 0.007 and Ratio, P = 0.0011) and quantification of the synovial RANKL + THY1 −/+ cells by flow cytometry (c; numbers, percentage of cells; n = 8 mice per group; P ≤ 0.0001). d, Effect of FAPα + THY1 − and FAPα + THY1 + cells on the number of osteoclasts (N. Oc; n = 4 mice per group; P ≤ 0.0001) and matrix degradation as assessed by resorption area (black) of Osteo Assay plates (left) and quantified as percentage degradation (n = 8 mice per group; P = 0.033). e, Effect of intra-articular (IA) injection of PDPN + FAPα + THY1 − or PDPN + FAPα + THY1 + cells into the ankle joints of day 3 STIA mice compared to contra-lateral shaminjected joints, with AUC analysis (n = 8 mice per group; P ≤ 0.0001). f, Flow cytometric analysis of absolute number of leukocyte subsets isolated from the digested synovia of injected joints at day 12 (n = 8 mice per group). Leukocytes THY1 + versus THY1 − , P = 0.0002; THY1 + versus sham, P ≤ 0.0001; neutrophils THY1 + versus THY1 − and THY1 + versus sham, both P ≤ 0.0001; macrophages THY1
+ versus sham, P = 0.0133. g, h, Representative images at day 12 (g) and quantification of micro-CT data and histomorphometric analysis of osteoclast number, cartilage damage, bone erosion and synovial pannus (h; n = 16 mice per group; area destained cartilage THY1
− versus sham, P = 0.0026, all others P ≤ 0.0001). Scale bar, 100 μm. 
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Data reporting. For mice experiments, assessors were blinded to allocation, and experiments were randomized. Statistics were performed to determine sample size; see Reporting Summary for further details. Human subjects research. Human subjects research was performed according to the Institutional Review Boards at Partners HealthCare, Hospital for Special Surgery and the West Midlands and Black Country Research Ethics Committee via approved protocols with appropriate informed consent. The study was compliant with all relevant ethical regulations. Synovial tissues and clinical outcome data of patients included in the early arthritis patient cohort in Birmingham (BEACON) were used in this study 10 . All patients were naïve to treatment with disease modifying anti-rheumatic drugs (DMARDs) and corticosteroids at inclusion. Control synovial tissue was obtained from uninflamed joints of patients with joint pain but normal imaging studies undergoing exploratory arthroscopy. Samples from patients with osteoarthritis were obtained from arthroplasty procedures and tissue from patients with RA obtained by ultrasound guided synovial biopsy as previously described 10, 15 . Human synovial tissue processing, histological analysis and immunofluorescence staining. Synovial tissue samples were frozen in Tissue-Tek OCT medium (Miles) or formalin fixed and paraffin embedded (FFPE).
For immunohistochemistry, antigen retrieval was performed at pH 9 on FFPE sections using Tris-EDTA, 0.05% Tween 20 (10 mM Tris Base, 1 mM EDTA Solution, 0.05% Tween 20) . Sections were stained using anti-FAPα (R&D Systems) and anti-goat horseradish peroxidase (HRP) (Dako). HRP staining was developed using the ImmPACT DAB Peroxidase HRP Substrate (Vector Labs). Images were acquired using the Zeiss Axio Scan and analysed with Zen lite 2012 software (Zeiss). Number of pixels was quantified and divided by a manually defined tissue area and the average number of pixels per unit area was calculated.
For immunofluorescence, acetone-fixed frozen sections were incubated with anti-FAPα (F11-24, eBioscience), anti-PDPN (NZ-1.3, eBioscience) and anti-THY1 (Thy-1A1, R&D Systems). These were detected with goat anti-mouse IgG1 FITC, anti-mouse IgG2a TRITC and anti-mouse IgG2b Cy5 (all Southern Biotech). To increase signal from FITC-channel, goat anti-FITC Alexa-488 antibody (Invitrogen) was used. Images were acquired using a Zeiss LSM 510 confocal microscope and ZEN pro 2011 imaging software. Human fibroblast cell culture. Primary human fibroblasts were isolated as described 17 and cultured in Dulbecco's modified Eagle's medium (DMEM) (SigmaAldrich) with 2% fetal bovine serum (FBS; Gemini), 2 mM l-glutamine, antibiotics (penicillin and streptomycin), and essential and non-essential amino acids (Life Technologies). Fibroblast lines at passage 3 or 4 were used for in vitro experiments. Enzymatic digestion of human synovial tissue. Synovial tissue samples were disaggregated into single cell suspension as previously described 18 . Synovial tissue fragments were separated using Liberase TL (100μg/ml; Sigma-Aldrich) and DNase I (100μg/ml; Roche) in RPMI in a 37 °C water bath for 30 min. Single cell suspensions were assessed for cell quantity and cell viability. Mass cytometry on human synovial cells. Cryopreserved disaggregated human synovial cells were thawed into RPMI + 10% FBS (HyClone). Viability was assessed and cells were stained with primary antibody cocktails at 1:100 dilution (CD45, metal 89Y, clone HI30; PDPN, metal 156Gd, clone NC-08; FAP, metal 147Sm, Poly; THY1, metal 162Dy, clone 5E 10). All antibodies were obtained from the Longwood Medical Area CyTOF Antibody Resource Core. Cells were fixed and permeabilized using the eBioscience Transcription Factor Fix/Perm Buffer followed by staining for intracellular markers. Cells were re-fixed in formalin (Sigma-Aldrich), washed with Milli-Q water, and analysed on a Helios (Fluidigm). Mass cytometry data were normalized using EQ Four Element Calibration Beads (Fluidigm) viSNE analyses were performed on cytometry data, using the BarnesHut SNE implementation on Cytobank (www.cytobank.org). All biaxial gating was performed using FlowJo v.10.0.7. Histological analysis of human synovial biopsy tissue. Haematoxylin and eosin (H&E)-stained sections of synovial biopsy tissue samples were scored for the severity of inflammatory infiltrate using the inflammatory component of the Krenn synovitis score 19 . Inflammatory infiltrates were graded from 0 to 3 (0, no inflammatory infiltrate; 1, few mostly perivascular situated lymphocytes or plasma cells; 2, numerous lymphocytes or plasma cells sometimes forming follicle-like aggregates; 3, dense band-like inflammatory infiltrate or numerous large follicle-like aggregates). Sections were scored by two blind individuals and then provided consensus. Mice. All animal experiments were approved by the UK Home Office and conducted in accordance with the UK's Animals (Scientific Procedures) Act 1986 and the UK Home Office Code of Practice. The project and experimental protocols were approved by the University of Birmingham Animal Ethics Review Committee who provided ethical oversight of the study.
C57BL/6 mice were purchased from Charles River and DBA/1 mice from Envigo. FAPα-DTR transgenic (Tg) embryos were a gift from D. Fearon, generated as previously described 13 . ROSA mT/mG mice were purchased from Jackson laboratory and bred in the unit. All mice were housed at a barrier and specific pathogen-free facility at the Biomedical Services Unit, University of Birmingham. All mice used in experimental studies were male or females aged 8-10 weeks. Single animals were considered as experimental units. In vivo imaging. FAPα-DTR mice were injected intraperitoneally with 150 μg/g body weight d-luciferin (PerkinElmer) and serially imaged using IVIS (Xenogen). The count data was normalized and expressed as radiance units of photons/second/ cm 2 /steradian (normalized bioluminescence) using Living Image software v.4.7 (PerkinElmer) and presented as percentage change from baseline signal. Diphtheria toxin-mediated deletion of FAPα-expressing cells. Diphtheria toxin (List Biological Laboratories) was administered by intraperitoneal injection of FAPα-DTR mice (25 ng/g), twice a day, both in prophylactic (at day −7 and −5 before STIA) and in therapeutic regimes (at days 3 and 5 or at days 5 and 7 or at days 10 and 12 after STIA). For the persistent inflammatory arthritis model, diphtheria toxin injections (25 ng per g body weight) were performed on day 3 and day 5 initially and then once a week. For local deletion of FAPα + cells, diphtheria toxin (5ng per g body weight) was administrated by intra-articular injection into the talo-tibial joint at day 4 and 6 after STIA. Sterile water was used as vehicle control for injections. Mouse models of inflammatory arthritis. STIA was induced by intravenous injection of 100 μl arthritogenic serum from KRN mice (K/BxN) 12 . Ankle or wrist joint thickness was monitored using callipers and reported as the change from baseline. In the persistent model of arthritis, mice were administered 100 μl arthritogenic serum intravenously at day 0 and then 50 μl once a week. Severity of joint swelling was quantified using the AUC analysis of serial measurements.
For BrdU incorporation, mice were injected with 100 μl of 10 mg/ml BrdU in PBS and then kept on BrdU-containing drinking water (0.8 mg/ml).
For collagen-induced arthritis male DBA/1 mice were immunised with 100 or 200 μg of rat CII emulsified 1:1 in complete Freund's adjuvant (CFA; Difco, containing Mycobacterium butyricum, 0.5 mg/ml) or Freund's incomplete adjuvant (IFA) containing Mycobacterium tuberculosis H37Ra (Difco; 3.33 mg/ml). Mice were boosted 3 weeks later with 100 μg CII in IFA. Mouse synovial tissue digestion. Bones with intact joints were dissected and transferred into RPMI-1640 (+2% FCS) containing 0.1 g/ml collagenase D (Roche), 0.01 g/ml of DNase I (Sigma-Aldrich). Samples were incubated at 37 °C, 40 min, followed by incubation with medium containing 0.1 g/ml collagenase dispase (Roche) and 0.01 g/ml DNase I at 37 °C for 20 min. Flow cytometry and cell sorting. Cells were stained at 4 °C and dead cells excluded using Zombie Yellow staining (BioLegend). Peripheral blood was collected by cardiac puncture into EDTA tubes, centrifuged and red cell lysis performed before staining. Antibodies used were anti-CD45 (30-F11), anti-THY1 (53-2.1), antipodoplanin (8.1.1), streptavidin-APC (17-4317-82) , anti-CD31 (390), anti-CD11b (M1/70), anti-SiglecF (1RNM44N), anti-CD11c (N418), anti-ITGA7 (334908), from eBioscience; anti-Ly-6G (1A8), anti-CD64 (X54-5/7.1), anti-F4/80 (BM8), anti-RANKL (IK22/5), anti-Ki67 (11F6), anti-CD140b (APB5), anti-CD146 (ME-9F1), anti-CD115 (AFS98), anti-CD43 (S11), anti-MHC Class II (39-10-8) and anti-Ly-6C (HK1.4), from BioLegend; anti-FAPα (R&D Systems), mouse anti-goat/sheep IgG biotin (GT-34, Sigma Aldrich); and anti-BrdU (3D4, BD Biosciences). BrdU staining was performed according to manufacturer's instructions using a BrdU Flow Kit (BD Pharmigen). CountBright absolute counting beads (Thermofisher) were used for analysis of cell numbers by flow cytometry, according to the manufacturer's guidelines. Samples were acquired using a BD LSR Fortessa and analysed by FlowJo, v.10.5.3. Cell sorting was performed immediately after staining using a MoFlo Astrios EQ machine (Beckman Coulter). For sorted populations, purity was determined by reanalysis for the target population based on cell surface markers immediately post sorting. Purity was >99% for each target population. Generation and analysis of droplet-based single-cell RNA sequencing data.
Following sorting, CD45
− live synovial cells isolated from hind limbs of day 9 STIA inflamed mouse joints (n = 3 biological replicate samples, each consisted of cells isolated from the joints of three animals) were captured with the 10x Genomics Chromium system. Sequencing libraries were generated using the 10x Genomics Single Cell 3′ Solution (version 2) kit and subjected to Illumina sequencing (HiSeq 4000, read 2 sequenced to 75 bp). Alignment, quantitation and aggregation of sample count matrices was performed using the 10x Genomics Cell Ranger pipeline (v.2.1.0) and mouse reference sequences (v.2.1.0), retaining a median of 59,900 reads per cell (mapped-read depth normalization applied). To circumvent known index-hopping issues with the HiSeq 4000 platform 20 cell barcodes common to more than one sample were removed from the aggregated count matrix. The UMI count matrix was randomly downsampled to a common median number of per-cell counts between the samples. Downstream analysis was performed using the Seurat R package (v.2.3.0) 16 as follows. Cells with greater than 5% mitochondrial reads or fewer than 500 genes were excluded from the analysis. Cells were downsampled to a common number: for the full analysis we retained n = 938 cells per replicate, while n = 575 cells were retained per replicate for reanalysis of the fibroblasts. Per-cell counts were normalized, scaled and the effects of total UMI counts and percentage of mitochondrial counts regressed out. For the fibroblast reanalysis, the difference between G2M and S phase was also regressed out based on the expression of known cell-cycle marker genes 21 . In both cases, we retained the first 30 principal components for t-SNE projection and clustering analysis (original Louvain algorithm, resolution set to 0.6 for the full analysis and to 0.4 for the fibroblast reanalysis). Conserved cluster markers were identified as the intersection of those that were significant in separate tests of the cells from the each replicate (Wilcoxon test, Benjamini-Hochberg adjusted P <0.1). Only genes found in 10% of cells (either within or outside the cluster of interest) and that showed a minimum log fold difference of 0.25 were tested for differential expression. Gene set over-representation analysis of cluster marker genes was performed using one-sided Fisher's exact tests (as implemented in the 'gsfisher' R package https://github.com/sansomlab/ gsfisher/) with 'biological process' gene sets obtained from the GO database 22 . For this analysis, cluster-specific gene universes were defined as those genes expressed in at least 10% percent of cells (either within or outside the cluster of interest). The computational analyses were performed using the 'pipeline_cellranger.py' and 'pipeline_seurat.py' pipelines (https://www.github.com/sansomlab/tenx/).
The diffusion map was generated using the 'RunDiffusion' function in Seurat and the first five principal components. The pseudotime tool Slingshot 14 was used to determine possible lineages via fitting of minimum spanning trees to the clusters (30 diffusion components, start cluster 'F1'). The clusters and cluster markers from the human dataset 15 were obtained using the same workflow as described above (30 principal components and perplexity 100 for t-SNE, resolution 0.6 for clustering). Only cells from RA patients and defined as fibroblasts by the authors were used in this analysis. Bulk cell population RNA sequencing. For these studies, cells were isolated from the synovia of digested hind limb joints of day 9 STIA mice and analysed by flow cytometry. After gating for fibroblasts (gating strategy outlined in Extended Data Fig. 1b ) cells were sort-purified into selected populations according to the sorting strategy in Extended Data Fig. 9a (each n represents a single mouse with cells isolated from the joints of both hind limbs) and collected in EDTA-free buffer. RNA was extracted from freshly isolated cells using the PicoPure RNA isolation kit (Thermo Fisher Scientific) according to the manufacturer's instructions. RNA quantity measured on the Qubit using the RNA HS kit (Invitrogen Q32852). Where samples were <5 ng/μl the Quantifluor RNA System was used (Promega E3310). cDNA synthesis was performed on isolated RNA using the SMART-Seq v.4 Ultra Low Input RNA Kit for Sequencing (ClonTech 634890). Libraries were pooled and sequenced paired end 75 bases each end with the illumina NextSeq 500 system.
The reads were mapped to the GRCm38 (Ensemble release 85) mouse genome using STAR alignment software version v.2.5.2b 23 . Read counts per gene were produced by the same software. Sample normalization and differential expression analysis was performed using DESeq2 R Bioconductor package 24 . log 2 -transformed values of read counts regularized by DESeq2 were used in heat maps in Extended Data Fig. 9 . Gene set enrichment analysis was performed using GAGE R Bioconductor package 25 with gene sets from the GO database. Luminex analysis. Cells were stimulated with 1ng/ml recombinant mouse TNF (Peprotech) ex vivo in culture medium for 1 h. Fresh culture media was then applied and the subsequent supernatant was harvested after 12 h and analysed using custom selected multiplex bead based assays (Luminex assay panel, R&D Systems). Co-culture synovial fibroblasts-osteoclasts. Sorted synovial fibroblasts were cultured in DMEM (+10% FCS, +1% GPS). Bone marrow was flushed out from tibiae and femurs of 8-10 weeks old C57BL/6 or GFP mice and osteoclast precursors were cultured 24 h in alpha-MEM (+10% FCS, +1% glutamine-penicillinstreptomycin (GPS)). Supernatant from the bone marrow culture was removed (containing haematopoietic osteoclast precursors), cells were seeded on top of the fibroblast culture in α-MEM (+10% FCS, +1% GPS, 1 μM prostaglandin E2, 10 ng/ml recombinant TNF). The experiment was stopped after 5 to 6 days in co-culture. Wells were imaged using Zeiss Observer Z1 microscope (ZEISS). GFP-positive osteoclasts were counted using Zen 2010 software. Resorption area in wells of Osteo Assay surface plates were analysed using Adobe Photoshop v.19.1.6, and ImageJ v1.51 . Quantitative reverse transcription PCR. RNA was isolated from single-cell suspensions using the PicoPure RNA isolation kit (Thermo Fisher Scientific) according to the manufacturer's instructions. For whole-tissue analysis, frozen joints were pulverized in liquid nitrogen using a FreezerMill 6770 (Spex Sample Prep) and mRNA extracted using ReliaPrep RNA Tissue Miniprep System (Promega). cDNA synthesis was performed on all samples (500 ng of RNA was transcribed) using iScript cDNA synthesis kit (Bio-Rad) on a Techne 312 thermal cycler PCR machine.
In order to amplify small amounts of cDNA without introducing amplification bias, TaqMan PreAmp Master Mix was used according to manufacturer's instructions for flow-sorted cell samples.
Reverse transcription with quantitative PCR (RT−qPCR) was performed using Taqman assays and Taqman universal Mastermix (from Applied Biosystems) on a real-time PCR detection system (CFX96 Touch Real-Time PCR Detection System).
Expression levels were normalized to an internal housekeeping gene (RPLP0 for human, Actb for mouse) and calculated as
, where C Tgene refers to the cycle threshold for the target gene amplification and C Thk refers to the cycle threshold for the housekeeping reference gene. TaqMan primer or probes (Applied Biosystems) used were Fap (human: Hs00990791_m1; mouse: Mm01329177_m1),
Mouse tissue histology and immunofluorescence staining. Mouse legs were fixed for 24 h in 10% formalin solution (Sigma-Aldrich) and decalcified in 10% EDTA (pH 7.4). Samples were embedded in paraffin, sectioned and H&E staining was performed at the Royal Orthopaedic Hospital Pathology Laboratories according to the standard protocol. Safranin O staining for cartilage was performed as previously described 26 . Antigen retrieval was performed on FFPE tissue sections; 0.05% trypsin-EDTA for PDPN, FAPα and cathepsin K staining at 37 °C, or citrate buffer pH 6 (Dako) at 58 °C for F4/80 staining. Sections were stained with primary antibodies: PDPN (eBio8.1.1, eBioscience), FAPα (R&D), F4/80 (BioRad), CD146 (Abcam) or cathepsin K (Abcam). Secondary antibodies used were: biotin goat anti-hamster IgG antibody (BioLegend); biotin rabbit anti-sheep IgG (Vector Labs) biotin goat anti-rabbit IgG (H+L) (Life Technologies); biotin rabbit anti-rat IgG (H+L) (Vector Labs), followed by streptavidin-HRP and DAB detection or alkaline phosphatase, Vector Labs. Tissue sections were imaged using the AxioScanZ.1 slide scanner and analysed using Zen lite 2012 software. Quantification by pixel counts was performed using Image J v.1.51.
For immunofluorescence, limbs were placed in a cryomold, embedded in OCT compound (both from Sakura Finetek) and stored at −80°C. Frozen sections were obtained with a tape transfer system CryoJane (Leica Biosystems) and staining was performed on acetone-fixed sections with anti-PDPN (eBio8.1.1, Thermofisher), anti-FAPα (Abcam) and anti-THY1 (53-2.1, Thermofisher). The following secondary antibodies were used: streptavidin-Alexa Fluor 555, goat anti-rabbit IgG (H+L) FITC, fluorescein/oregon green polyclonal antibody Alexa Fluor 488, goat anti-rat IgG (H+L) Alexa Fluor 647, from Invitrogen; and biotin goat anti-hamster IgG (BioLegend). Images were acquired using a Zeiss LSM780 confocal microscope and ZEN pro 2011 imaging software. Histomorphometry scoring. Analysis and cell counting of H&E and Safranin O was performed on images from whole joint tissue sections as previously described 27 . Leukocyte infiltration was scored 0-3 (0, normal; 1, minimal infiltration; 2, moderate infiltration; 3, marked infiltration). Osteoclasts were detected by both morphology and cathepsin K staining. Scoring and measurements were performed by two independent blinded assessors on a consistent region of the ankle joint and on three different cutting levels and expressed as a mean of these measurements. Adoptive transfer of fibroblasts. Live sorted, purified cells (500,000, from day 9 STIA) were injected into the inflamed talo-tibial joint of day 3 STIA recipient mice. The contralateral joint was injected with PBS. For CIA, cells were sort-purified and injected into the talo-tibial joint of DBA/1 mice with CIA at the first sign of arthritis, under the same experimental conditions described above. Tracking of adoptively transferred cells in vivo. Cells were sort-purified from digested synovia of day 9 STIA ROSA mTmG mice and injected as described above. Collected tissue was mounted in OCT, frozen, sectioned and fixed in acetone. For flow cytometry, sort-purified cells were labelled with a cell trace dye (Invitrogen) according to the manufacturer's instructions before injection. Micro-CT analysis. Hind limbs were imaged using a Skyscan 1172 micro-CT scanner (Bruker) using settings and reconstruction algorithms using MeshLab, v.1.3.2, Letter reSeArCH as previously described 26 . Micro-CT meshes were divided into three regions: heel (compromising the calcaneus, centrale, distal tarsals, tibulae and astagalus and distal tibia and fibula), metatarsals and phalanges (excluding the claws). Each region was scored for erosion (0, normal; 1, roughness; 2, pitting; 3, full thickness holes) and the extent of the area affected (0, none; 1, a few small areas; 2, multiple small-medium areas; 3, multiple medium-large areas). The two scores were then multiplied together for each region. With the exception of local deletion and intra-articular cell transfer studies, micro-CT scores from both the front and hind limb were combined as an average for each mouse. Statistical analysis. Statistical analysis was performed as described in each section using Prism 8 software. Unless otherwise stated, data are presented as mean ± s.d. from data obtained from at least two independent experiments. Parametric and non-parametric analyses were used where appropriate based on testing for a normal distribution using the D' Agostino-Pearson omnibus normality test. Differences were considered to be significant when P <0.05. Multiple testing corrections were applied where appropriate. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
STIA single cell and bulk fibroblast RNA sequencing data that support the findings of this study have been deposited in Gene Expression Omnibus (GEO) with the accession codes GSE129087 and GSE129451. Source Data for Figs. 1, 2, 4 and Extended Data Figs. 1-3, 10 are provided with the online version of the paper.
Code availability
The source code repository of the computational pipeline for single-cell data analysis and integration is located at https://www.github.com/sansomlab/tenx/. + , brown; nuclei, blue) in the ankle joint tissue sections at day 12 STIA mice following diphtheria toxin at day 3 and 5 (representative of n = 6 mice). e, Percentage of F4/80 + macrophages staining positive for MHC class II as detected by flow cytometry in day 12 STIA digested synovia from DTR +/− mice following diphtheria toxin at day 3 and 5 (n = 13 mice per group). f, Expression of functional macrophage markers detected by RT−qPCR in sort-purified macrophages (CD45 + CD11b + F4/80 + ) isolated from the synovia of day 12 STIA mice following diphtheria toxin at day 3 and 5 (n = 7 mice per group). g, h, Number of FAPα expressing cells quantified by flow cytometry from digested synovia (n = 8 mice), popliteal (draining) and mesenteric (non-draining) lymph nodes (n = 6 mice) following intra-articular administration of diphtheria toxin into the ankle joint during STIA (harvested day 14) (g) and daily change in weight from baseline (expressed as percentage of original body weight) in STIA mice compared to non-arthritic mice (h) (n = 6 mice). i, Effect of local deletion of synovial FAPα-expressing cells (by intra-articular injection of diphtheria toxin) on ankle joint thickness in the resolving model of STIA model when compared to the wrist joints on the same mouse (non-deleted limbs) (n = 8 mice) and to non-arthritic DTR + and DTR − injected mice (n = 6 mice per group) with AUC analysis. j, Representative micro-CT images of day 14 STIA and non-arthritic control mice following intraarticular injection of diphtheria toxin and quantification of bone erosion and new bone formation (STIA DTR − n = 10, STIA DTR + n = 13, DTR − and DTR + n = 8). k, Quantification of the number of fibroblasts and leukocytes in digested synovia of day 9 STIA mice analysed by flow cytometry following intra-articular administration of diphtheria toxin (n = 8 mice). Statistics: two-way ANOVA with Tukey's post hoc test (a, c, e, j, k), two-tailed paired Student's t-test (f, g), one-way ANOVA with Tukey's multiple comparison tests (i, j). Data are mean ± s.d., except in a, c, e, f, g, k and AUC analysis in i, which are shown as box plots (centre line, median; box limits, upper and lower quartiles; whiskers, maximum and minimum values).
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Reporting Summary
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted The 10x data was analysed using the 10x pipeline (www.github.com/sansomlab/tenx/tree/master/pipelines), which utilises the cellranger (v2.1.0) and Seurat packages (v2.3.0; R v3.4.2).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Laboratory animals
The study involved the following laboratory animals: C57BL/6 mice (purchased from Charles River). DBA/1 mice (purchased from Envigo). FAP-DTR transgenic mice (embryos were a gift from Prof Douglas Fearon and mice were bred in house). ROSAmT/mG mice (purchased from Jackson laboratory and bred in the unit). All mice used in experimental studies were male or females aged 8-10 weeks old weighing between 20-22g.
Wild animals
The study did not involve the use of wild animals Field-collected samples
The study did not involve samples collected from the field.
Ethics oversight
The animal experiments were approved by the U.K. Home Office and conducted in accordance with the U.K.'s Animals (Scientific Procedures) Act 1986 and the U.K. Home Office Code of Practice. The project and experimental protocols were also approved by the University of Birmingham Animal Ethics Review Committee who provided ethical oversight of the study.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Human research participants
Policy information about studies involving human research participants
Population characteristics
For immunohistochemistry and confocal immunofluorescence studies using human synovial biopsy tissue the following patients were included: control n=8 patients (mean age 41 years, range 23-49 years, females, n=3 (38%); resolving (mean age 44 years, range 32-55 years, females n=3 (27%); rheumatoid arthritis n=11 (mean age 53 years, range 43-70 years, females n=4 (36%)). For mass cytometry (CyToF) studies the following patients were included: patients with osteoarthritis n=15 (mean age 71 years, range 64-81 years, females n=10 (67%)) and rheumatoid arthritis n=8 (mean age 56 years, range 51-71 years, females n=5 (63%)). In addition, in the sub-analysis of human RNA single cell sequencing data the following patients were included in the dataset: patients with rheumatoid arthritis n=20 (mean age 58 years, range 38-78 years, females n=17 (85%)).
All patients were naïve to treatment with disease modifying anti-rheumatic drugs (DMARDs) and corticosteroids at inclusion. Diagnostic and prognostic outcomes were assigned after 18-months of follow-up. Patients were classified as having RA according to the 2010 ACR/EULAR classification criteria for RA or were classified as having self-limiting resolving disease if they had no clinical evidence of synovial swelling and had not taken DMARDs or received glucocorticoid treatment in any form in the preceding 3 months.
Recruitment
Synovial tissues and clinical outcome data of patients included in the early arthritis patient cohort in Birmingham (BEACON) were used in this study. BEACON is an inception cohort recruiting patients from unselected early arthritis clinics in Birmingham UK to which patients are directly referred for rapid review by primary care physicians. Patients with clinical synovitis present in at least one synovial joint (of 66 joints examined) were recruited to the cohort if symptom duration, defined as any symptom attributed by the assessing rheumatologist to inflammatory joint disease (pain, stiffness and/or swelling), was no greater than 3 months. All studies were approved by local medical ethical committees and patients gave written, informed consent to participate.
Ethics oversight
Human subjects research was performed according to the Institutional Review Boards at Partners HealthCare, Hospital for Special Surgery and the West Midlands and Black Country Research Ethics Committee via approved protocols Note that full information on the approval of the study protocol must also be provided in the manuscript.
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Methodology Sample preparation
For mice, single cell samples were created from digested synovial membrane (collegnase digestion, outlined in methods) or from whole blood obtained by cardiac puncture and treated with EDTA. Red cell lysis was performed and staining performed on the remaining single cell suspension. For human tissue, single cell suspensions were acquired by enzymatic digestion of synovial tissue obtained by ultra-sound guided biopsy.
